According to a new report by Polaris Market Research, the global pharmaceutical contract development & manufacturing organization (CDMO) market was valued at USD 192.19 billion in 2024 and is projected to reach USD 418.65 billion by 2034, expanding at a CAGR of 8.11% over the forecast period. Growth is underpinned by rising R&D expenditure to expand product pipelines,...